The effect of quinolinate on rat brain lipid peroxidation is dependent on iron

Neurochemistry International

Volumn 30, Issue 2, 1997, Pages 233-237

  Stipek, S ^a   Stastny, F ^a   Platenik, J ^a   Crkovska, J ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DEFEROXAMINE; FERROUS SULFATE; IRON; LIPID; MALONALDEHYDE; QUINOLINIC ACID; THIOBARBITURIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN METABOLISM; COMPLEX FORMATION; CONTROLLED STUDY; HEMISPHERE; IRON CHELATION; LIPID BRAIN LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROSCOPY;

ANIMALIA;

ANIMALS; ASCORBIC ACID; BRAIN; DEFEROXAMINE; IRON CHELATING AGENTS; LIPID PEROXIDATION; MALE; QUINOLINIC ACID; RATS; RATS, WISTAR; SIDEROPHORES;

EID: 0031024185     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00067-8     Document Type: Article

References (28)

1. Babizhayev M.A. The biphasic effect of calcium on lipid peroxidation Arch. Biochem. Biophys. 266 1988 446 451
2. Batshaw M.L. Robinson M.B. Hyland K. Djali S. Heyes M.P. Quinolinic acid in children with congenital hyperammonemia Ann. Neurol. 34 1993 676 681
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. Browers P. Heyes M.P. Moss H.A. Wolters P.L. Poplack D.G. Markey S.P. Pizzo P.A. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationship to clinical status and therapeutic response J. Infect. Dis. 168 1993 1380 1386
5. Carbonneau M.A. Peuchant E. Sess D. Canioni P. Clerc M. Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma Clin. Chem. 37 1991 1423 1429
6. Chakrabarti A.K. Bag S.P. Spectrophotometric evaluation of formation constants. 1:2 metal-ligand system: iron(II)-quinolinic acid complex Fresenius' Z. anal. Chem. 254 1973 269
7. Daniel L.C. N-methyl- d -aspartate increases cytoplasmic free calcium in mouse hippocampus Neuropharmacology 30 1991 539 545
8. During M.J. Heyes M.P. Freese A. Markey S.P. Martin J.B. Roth R.H. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systematic l -tryptophan loading Brain Res. 476 1989 384 387
9. Foster A.C. Schwarcz R. Neurotoxic effects of quinolinate in the mammalian central nervous system Stone T.W. Quinolinate and the Kynurenines 1989 CRC Press Inc. Boca Raton, Florida 173 192
10. Goodwin J.F. Whitten C.F. Chelation of ferrous sulphate solutions by desferrioxamine B Nature 205 1965 281 283
11. Grünwald R.A. Ascorbic acid in the brain Brain Res. Rev. 18 1993 123 133
12. Gutteridge J.M.C. The effect of calcium on phospholipid peroxidation Biochem. Biophys. Res. Comm. 74 1977 529 537
13. Halliwell B. Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease Biochem. J. 219 1984 1 14
14. Halliwell B. Gutteridge J.M.C. Free Radicals in Biology and Medicine 2nd edn. 1995 Clarendon Press Oxford
15. Keilhoff G. Wolf G. Sˇtastný F. Schmidt W. Quinolinate neurotoxicity and glutamatergic structures Neuroscience 34 1990 235 242
16. Martin A. Heyes M.P. Salazar A.M. Kampen D.L. Williams J. Law W.A. Coats M.E. Markey S.P. Progressing slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals J. Neuropsychiatry Clin. Neurosci. 4 1992 270 279
17. McLarnon J.G. Curry K. Quinolinate activation of N -methyl- d -aspartate ion channels in rat hippocampal neurons Neurosci. Lett. 116 1990 341 346
18. Miller D.M. Aust S.D. Studies of ascorbate-dependent, iron-catalyzed lipid peroxidation Arch. Biochem. Biophys. 271 1989 113 119
19. Miller D.M. Spear N.H. Aust S.D. ffects of deferrioxamine on iron-catalyzed lipid peroxidation Arch. Biochem. Biophys. 295 1992 240 246
20. Minotti G. Aust S.D. The requirement for iron(III) in the initiation of lipid peroxidation by iron(II) and hydrogen peroxide J. Biol. Chem. 262 1987 1098 1104
21. Moroni F. Lombardi G. Carla V. Lal S. Etienne P. Nair N.P.V. Increase in content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure J. Neurochem. 47 1986 1667 1671
22. Ríos C. Santamaría A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates Neurochem. Res. 16 1991 1139 1143
23. Santamaría A. Ríos C. MK-801, an N -methyl- d -aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum Neurosci. Lett. 159 1993 51 54
24. Schaich K.M. Preparation of metal-free solutions for studies of active oxygen species Methods Enzymol. 186 1990 121 125
25. Tsuzuki K. Iino M. Ozawa S. Change in calcium permeability caused by quinolinic acid in cultured rat hippocampal neurones Neurosci. Lett. 105 1989 269 274
26. Wolfensberger M. Amsler U. Cuenod M. Foster A.C. Whetsell W.O. Jr. Schwarcz R. Identification of quinolinic acid in rat and human brain tissue Neurosci. Lett. 41 1984 247 252
27. Zaleska M.M. Floyd R.A. Regional lipid peroxidation in rat brain in vitro : possible role of endogenous iron Neurochem. Res. 10 1985 397 410
28. Zima T. Sˇtípek S. Crkovská J. Pláteník J. Measurement of lipid peroxidation product malondialdehyde in biological samples by spectrophotometric and HPLC assay Clin. Biochem. Metab. 2 1995 98 102